Melanie DuBois

Health Technology

Consumer Services

Profile

Melanie DuBois worked as a Director of Quality Assurance at YM BioSciences, Inc. and as a Manager of Quality Assurance at GlaxoSmithKline Pharmaceuticals SA (Belgium).
She received an undergraduate degree from Toronto Metropolitan University in 1987.

Former positions of Melanie DuBois

Companies	Position	End
GlaxoSmithKline Pharmaceuticals SA (Belgium) GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium.	Corporate Officer/Principal	2005-12-31
YM BioSciences, Inc. YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.	Corporate Officer/Principal	-

See the detail of Melanie DuBois's experience

Training of Melanie DuBois

Toronto Metropolitan University of

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Melanie DuBois's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
YM BioSciences, Inc. YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.	Health Technology
GlaxoSmithKline Pharmaceuticals SA (Belgium) GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium.	Health Technology